Innospec (IOSP) Could Be 6% Undervalued After Strong First Half Results
Innospec (IOSP) reported strong first-half 2026 results with increased sales and net income, alongside ongoing share repurchase activities. Despite an 11.39% 30-day share
What Innospec (IOSP)'s Strong Q2 Earnings and Completed Buyback Mean For Shareholders
Innospec Inc. (IOSP) reported strong Q2 2026 earnings with increased sales and net income, alongside completing a $34.87 million share repurchase program. The company's investment narrative focuses on turning specialized chemicals into consistent earnings despite raw material volatility and shifts in transportation fuels. Forecasts project significant revenue and earnings growth by 2029, suggesting a fair value upside for shareholders.
Innospec Inc (0JAX) Q1 2026 Earnings Report - Results, Call & Slides
Innospec Inc (0JAX) reported its Q1 2026 earnings, beating both EPS and revenue expectations. The company posted an actual EPS of $1.05 against a consensus of $1.01, and actual revenue of $453.20M compared to an expected $432.14M, representing a 2.81% year-over-year revenue growth. Innospec's next earnings report is estimated for November 10, 2026.
Innospec Inc (0JAX) Q1 2024 Earnings Report - Results, Call & Slides
This article details Innospec Inc.'s (0JAX) Q1 2024 earnings report, revealing an EPS beat at $1.75 against a consensus of $1.64, while revenue of $500.20M missed expectations slightly. It includes information on the earnings call, slide deck availability, and historical earnings data, alongside estimated future earnings dates.
Innospec stock hits 52-week high at 94.67 USD By Investing.com
Innospec Inc. (IOSP) stock reached a new 52-week high of $94.67, driven by strong performance and investor confidence, with a year-to-date return of 23% in 2026. The specialty chemicals company reported impressive Q2 2026 financial results, exceeding earnings and revenue expectations despite facing near-term supply constraints. InvestingPro analysis suggests the stock, with a market capitalization of $2.31 billion and a P/E ratio of 19.08, may still be undervalued.
Innospec stock hits 52-week high at 94.67 USD
Innospec Inc. (IOSP) stock has reached a new 52-week high of $94.67, driven by strong performance including a 12.15% gain over the past year and a 23% year-to-date return in 2026. This milestone follows impressive Q2 2026 financial results, where the company surpassed earnings and revenue expectations despite facing near-term supply constraints and mixed margin trends. InvestingPro analysis suggests the stock may be undervalued with a P/E ratio of 19.08.
Innospec stock hits 52-week high at 94.67 USD By Investing.com
Innospec Inc. (IOSP) stock has reached a new 52-week high of $94.67, driven by strong financial performance including adjusted earnings of $1.27 per share and revenues of $491.4 million in Q2 2026, both exceeding analyst expectations. The specialty chemicals company, with a market capitalization of $2.31 billion and a P/E ratio of 19.08, has seen a 12.15% increase over the past year and a 23% year-to-date return in 2026, though it faces near-term supply constraints and mixed margin trends.
Innospec stock hits 52-week high at 94.67 USD By Investing.com
Innospec Inc. (IOSP) stock reached a new 52-week high of $94.67, driven by strong Q2 2026 financial results that surpassed analyst expectations for both earnings and revenue. The specialty chemicals company boasts a market capitalization of $2.31 billion and a P/E ratio of 19.08, with its stock up 23% year-to-date in 2026. Despite positive performance, investors are monitoring near-term supply constraints and mixed margin trends.
Trading Systems Reacting to (IOSP) Volatility
This article analyzes Innospec Inc. (NASDAQ: IOSP) using AI models to generate trading strategies and signals. It identifies strong near and mid-term sentiment, potential upside, and provides specific long, breakout, and short strategies with entry, target, and stop-loss zones. The analysis also includes multi-timeframe signal strengths, support, and resistance levels for IOSP.
Innospec (IOSP) Is Up 7.5% After Debt-Free, Higher-Margin Q2 2026 Earnings Report – What’s Changed?
Innospec (IOSP) reported strong Q2 2026 results with sales rising to US$491.4 million and net income to US$30.8 million, driven by improved earnings and a debt-free balance sheet. This performance, coupled with a US$75 million share repurchase authorization, reinforces the company's financial flexibility, though risks like margin pressure in Performance Chemicals and softer Oilfield Services demand remain. The article discusses Innospec's investment narrative, fair value estimates, and key considerations for investors, highlighting its projected revenue of $2.2 billion and earnings of $167.5 million by 2029.
Assenagon Asset Management S.A. Sells 218,102 Shares of Innospec Inc. $IOSP
Assenagon Asset Management S.A. reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 44.4% in the second quarter, selling 218,102 shares and retaining 272,782 shares valued at approximately $22.2 million. Despite this reduction, institutional investors collectively own 96.64% of the company. Innospec recently exceeded quarterly expectations with $1.27 EPS and $491.4 million in revenue, leading to improved analyst sentiment with some "Buy" ratings and a consensus "Hold."
Innospec (IOSP) Is Up 7.5% After Debt-Free, Higher-Margin Q2 2026 Earnings Report – What’s Changed?
Innospec (IOSP) reported strong Q2 2026 results with sales rising to US$491.4 million and net income to US$30.8 million, leading to a 7.5% stock increase. The company achieved a debt-free balance sheet and authorized a US$75 million share repurchase. Despite positive earnings, risks like margin pressure in Performance Chemicals and softer Oilfield Services demand remain key factors for future performance.
Innospec Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:IOSP) 2026-08-08
Innospec Inc. (IOSP) has published its Q2 2026 earnings call presentation, detailing its financial results for the quarter. The company reported an EPS of $1.27, surpassing estimates by $0.22, and revenue of $491.40 million, which beat expectations by $34.17 million and represents an 11.76% year-over-year increase. This article provides access to the slide deck presented during the earnings call.
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
Innospec Inc. (IOSP) reported strong second-quarter 2026 results, with adjusted earnings of $1.27 per share and revenues of $491.4 million, both surpassing Zacks Consensus Estimates. The growth was broad-based across its Performance Chemicals, Fuel Specialties, and Oilfield Services segments. The company also highlighted its debt-free position, semi-annual dividend payment, and share repurchases, with management anticipating further improvements in the second half of the year.
Public Employees Retirement System of Ohio Reduces Holdings in Innospec Inc. $IOSP
The Public Employees Retirement System of Ohio significantly reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 96.6% in the first quarter, now holding only 687 shares valued at $50,000. Despite this reduction, Innospec reported strong quarterly earnings, beating analyst estimates with $1.27 EPS and revenue of $491.4 million. The company's stock is trading near its 52-week high, and while the overall analyst sentiment is "Hold," some firms like Seaport Research Partners maintain a "Buy" rating.
Innospec Inc (IOSP) (Q2 2026) Earnings Call Highlights: Strong Growth Across All Segments, but ...
Innospec Inc. (IOSP) reported strong Q2 2026 earnings with double-digit sales and operating income growth across all segments, driven by effective pricing and demand in Oilfield Services. Despite this, the company faced slight gross margin decreases in Performance Chemicals and Fuel Specialties due to supply constraints, weaker sales mix, and pricing lag. Management addressed facility repairs, capacity expansion, and growth drivers in the drag reducing agent (DRA) business, expecting additional capacity benefits in late Q4 2026 or Q1 2027.
Innospec Inc. $IOSP Shares Sold by Janus Henderson Group PLC
Janus Henderson Group PLC reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 11.7% in the first quarter, selling 17,579 shares but retaining 133,272 shares valued at approximately $9.7 million. Despite this, other major institutional investors like Assenagon Asset Management, Western Standard, Goldman Sachs, and Millennium Management significantly increased their positions. Innospec reported strong quarterly earnings of $1.27 EPS, beating estimates by $0.22, and an 11.8% year-over-year revenue increase to $491.4 million, yet analysts maintain an overall "Hold" rating for the stock which is trading near its 52-week high.
Arrowstreet Capital Limited Partnership Boosts Holdings in Innospec Inc. $IOSP
Arrowstreet Capital Limited Partnership significantly increased its stake in Innospec Inc. (NASDAQ:IOSP) by 196.5% in the first quarter, bringing its total holdings to 18,497 shares valued at $1.35 million. This move is part of a broader trend of institutional investors, who collectively own 96.64% of IOSP, adding to their positions. Innospec recently reported strong quarterly earnings of $1.27 per share, surpassing estimates, with revenue climbing 11.8% year over year to $491.4 million, contributing to the stock trading near its 12-month high.
Innospec Inc (IOSP) (Q2 2026) Earnings Call Highlights: Strong Growth Across All Segments, but ...
Innospec Inc. (IOSP) reported strong Q2 2026 earnings with double-digit sales and operating income growth across all segments, including significant gains in Performance Chemicals and Oilfield Services. Despite this, the company faced some challenges such as slightly decreased gross margins in Performance Chemicals and Fuel Specialties, largely due to supply constraints and sales mix issues. Management outlined plans for facility repairs and expansions expected to boost capacity and efficiency by late Q4 2026 or Q1 2027, expressing confidence in future growth while acknowledging near-term capacity limitations and margin pressures.
Innospec (NASDAQ: IOSP) grows Q2 2026 revenue 12% to $491.4M
Innospec Inc. reported strong Q2 2026 financial results with total revenue increasing 12% to $491.4 million, driven by broad-based growth across all segments. Net income attributable to Innospec rose to $30.8 million, and diluted GAAP EPS increased to $1.25. The company maintained a debt-free balance sheet with $250.2 million in cash and returned capital to shareholders through dividends and share repurchases.
Innospec Inc stock hits 52-week high at $92.31
Innospec Inc (IOSP) stock has reached a new 52-week high of $92.31, reflecting a 15.73% increase over the past year. InvestingPro analysis suggests the stock is currently undervalued. This milestone follows the company's strong Q2 2026 results, where adjusted earnings and revenue surpassed analyst expectations.
Innospec Inc stock hits 52-week high at $92.31 By Investing.com
Innospec Inc. (IOSP) stock reached a new 52-week high of $92.31, with a current market capitalization of $2.26 billion and a 15.73% increase over the past year. InvestingPro analysis suggests the stock is undervalued, and the company recently reported strong Q2 2026 results, surpassing analyst expectations with adjusted EPS of $1.27 and revenue of $491.4 million.
Earnings call transcript: Innospec tops Q2 2026 forecasts as shares rise
Innospec Inc. reported stronger-than-expected second-quarter 2026 results, with adjusted EPS of $1.27 and revenue of $491.4 million, surpassing Wall Street forecasts. The company's stock rose 2.7% following the announcement, driven by double-digit growth across all business segments and a debt-free balance sheet. Management highlighted ongoing plant repairs in Performance Chemicals, expected to increase capacity by over 10% by early 2027, and continued strong performance in Fuel Specialties and Oilfield Services.
INNOSPEC INC. Q2 2026: Revenue $491.4M, EPS $1.25— 10-Q Summary
Innospec Inc. reported strong second-quarter 2026 results, with revenue reaching $491.4 million and diluted EPS at $1.25, significantly up from the previous year. This growth was fueled by volume and mix gains across all segments, particularly Fuel Specialties and Performance Chemicals, and increased demand for higher-margin products. The company also saw improvements in net income and made operational progress, including plant expansion and ERP implementation, though adjusted working capital rose due to inventory increases.
Innospec Q2 2026 Earnings Call Transcript
Innospec reported a strong Q2 2026 with a 12% revenue increase to $491.4 million and net income up to $30.8 million. Performance Chemicals and Oilfield Services drove operating income growth, with Performance Chemicals plant repairs expected to increase capacity by over 10% by late Q4 2026 or early 2027. Fuel Specialties also saw revenue growth, though operating income growth was more modest due to sales mix and pricing lags, with management anticipating continued strong performance despite some Q3 margin pressure.
Earnings Flash (IOSP) Innospec Inc. Posts Q2 Adjusted EPS $1.27 per Share, Vs. FactSet Est of $1.05
Innospec Inc. (IOSP) announced its Q2 adjusted EPS of $1.27 per share, significantly surpassing the FactSet estimate of $1.05 per share. This indicates a strong financial performance for the company during the second quarter.
Innospec Reports Second Quarter 2026 Financial Results
Innospec Inc. announced strong financial results for the second quarter of 2026, with revenues up 12% to $491.4 million and operating income increasing by 16%. The company reported GAAP EPS of $1.25 and adjusted non-GAAP EPS of $1.27, driven by robust contributions from all business segments, particularly Fuel Specialties, Performance Chemicals, and Oilfield Services. Innospec maintained a debt-free balance sheet with over $250 million in net cash and returned value to shareholders through dividends and share repurchases.
Innospec Inc reports results for the quarter ended June 30 - Earnings Summary
Innospec Inc. has released its earnings summary for the quarter that ended on June 30. The full article, provided by Refinitiv, is available through TradingView for subscribers.
Earnings Flash (IOSP) Innospec Inc. Posts Q2 Adjusted EPS $1.27 per Share, vs. FactSet Est of $1.05
Innospec Inc. (IOSP) announced Q2 adjusted EPS of $1.27 per share, surpassing FactSet's estimate of $1.05. The company also reported Q2 revenue of $491.4 million, exceeding FactSet's estimate of $457.2 million. These results indicate a strong financial performance for Innospec Inc. in the second quarter of 2026.
Allspring Global Investments (IOSP) discloses 7.7% beneficial stake in Innospec
Allspring Global Investments Holdings, LLC has disclosed a 7.7% beneficial ownership stake in Innospec Inc. (IOSP) through an amended Schedule 13G filing. This represents 1,892,471 shares, with Allspring holding sole voting power over 1,891,583 shares and sole dispositive power over all 1,892,471 shares. No single client of Allspring's investment advisers holds more than five percent of Innospec's common stock.
How Innospec Inc. (IOSP) Affects Rotational Strategy Timing
This article analyzes Innospec Inc. (IOSP) using AI models to provide trading strategies for different risk profiles. It highlights strong near and mid-term sentiment, tests of resistance levels, and offers specific long, breakout, and short trading setups with defined targets and stop losses. The analysis also includes multi-timeframe signal strengths, support, and resistance levels for IOSP.
How Investors May Respond To Innospec (IOSP) Earnings Decline Expectations Amid Rising Revenue
Innospec (IOSP) is facing expectations of a year-over-year earnings decline for June 2026, despite projected revenue increases, with a negative Earnings ESP suggesting an earnings miss. This situation puts pressure on management to address margin profitability, especially following its recent removal from several Russell indices. The article highlights that Innospec's narrative projects significant revenue and earnings growth by 2029, with fair value estimates suggesting a potential upside, though investors should consider the risk of sustained margin pressure.
Innospec Inc (IOSP) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis for Innospec Inc (IOSP), noting its current valuation score of 6.12, ranking 59 out of 65 in the Chemicals industry. It highlights the company's current P/E ratio of 18.69 and mentions that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
Innospec Inc (IOSP) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Innospec Inc (IOSP), noting its current risk assessment score of 8.57, which ranks it 12th out of 65 in the Chemicals industry. The assessment highlights the company's beta value of 0.90, indicating less volatility than the overall market. It also details various risk metrics including maximum drawdown, volatility, Sharpe ratio, and liquidity.
IOSP|Innospec Inc|Price:84.875|Chg%:-1.025
Innospec Inc. (IOSP) is trading at $84.875, down 1.19%, with a market cap of $2.10 billion. The company's fundamentals are strong, and its valuation is considered fair within the Chemicals industry. Analysts have rated it "Buy" with a target price of $99.33.
Innospec Inc. (IOSP) Stock Forecasts
Argus has raised its target price for Innospec Inc. (IOSP) to $90.00, with the stock currently trading at $84.95. Innospec Inc. is a company that manufactures and sells chemicals and fuel additives, organized into three segments based on product type. The full report provides a detailed analysis for premium users.
Innospec Inc (IOSP) Financial Health: Profitability & Balance Sheet Analysis
Innospec Inc (IOSP) has a robust financial score of 7.76, placing it 20th out of 65 companies in the Chemicals industry. The company reported a quarterly revenue of $453.20 million, marking a 2.81% year-over-year increase, and its net profit grew by 7.32% year-over-year. While some data points for Quality of Earnings, Operational Efficiency, Growth Potential, and Shareholder Returns are not yet disclosed, the overall financial health and operating efficiency are noted as strong and average, respectively.
Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for
Analysts are predicting a year-over-year decline in earnings for Innospec (IOSP) in the quarter ended June 2026, despite expectations for higher revenues. The company's Earnings ESP of -0.47% combined with a Zacks Rank #2 makes it difficult to definitively predict an earnings beat, as the Most Accurate Estimate is lower than the Zacks Consensus Estimate. While Innospec has a strong history of beating EPS estimates, investors should consider other factors along with these metrics when evaluating the stock.
Innospec Inc (IOSP) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Innospec Inc (IOSP), detailing its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock is currently trading between resistance at $89.25 and support at $81.00, suggesting a range-bound swing trading opportunity. While some indicators show buy signals, the overall technical signal is neutral.
Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for
Innospec (IOSP) is expected to report a year-over-year decline in earnings but higher revenues for the quarter ended June 2026. While the consensus EPS estimate has been revised slightly higher recently, the company's Earnings ESP is negative, suggesting analysts have become more bearish. The article advises investors to consider other factors beyond just earnings surprises, especially given Innospec's recent performance history of beating EPS estimates.
Innospec Inc (IOSP) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides a detailed timeline of Innospec Inc (IOSP) dividends and stock splits, highlighting historical payout data. It shows that Innospec Inc has distributed $134.40 million in dividends over the past five years. The article lists specific dividend dates, including record, payment, and ex-dividend dates, along with the gross cash dividend amount for each entry.
Innospec Inc (IOSP) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Innospec Inc (IOSP), listing major institutional holders like BlackRock, Allspring Global Investments, and Vanguard. It also provides a breakdown of shareholder types, institutional shareholding trends over several quarters, and recent shareholder activity with changes in holdings. Additionally, it identifies ETFs that hold IOSP shares.
Innospec Inc. Revenue Breakdown – NASDAQ:IOSP
Innospec Inc. (NASDAQ: IOSP) generated $1.78 billion in revenue last year, with its top-performing segment, Fuel Specialties, contributing $701.50 million. The United States was the largest regional contributor, accounting for $951.70 million of the company's revenue.
Innospec Inc (IOSP) Cash Flow
This article provides a detailed cash flow statement for Innospec Inc (IOSP), breaking it down into operating, investing, and financing activities across various fiscal quarters and years. It highlights key financial figures such as operating cash flow, net income from continuing operations, capital expenditures, and free cash flow, along with their year-over-year changes. The document also includes an FAQ section defining different types of cash flow and their significance for investors.
Innospec Inc (IOSP) Earnings Forecast: Future EPS & Revenue Growth Estimates
Innospec Inc (IOSP) has an earnings forecast score of 8.00, ranking 6th out of 65 in the Chemicals industry. Analysts have set an average price target of $100.00 for IOSP, with a "Buy" trend based on 3 analyst ratings. The company's expected revenue for the next quarter is $456.80M, and EPS for the next quarter is projected at $1.04.
IOSP|Innospec Inc|Price:84.760|Chg%:+0.670
This article provides an overview of Innospec Inc (IOSP), detailing its stock performance, financial health, and institutional confidence. The company's fundamentals are highlighted as healthy with high growth potential, and its valuation is considered fairly valued within the Chemicals industry. Analysts have rated the stock as a "Buy" with a target price of $99.33, suggesting an anticipated upward trend in the medium term.
Innospec stock holds recent gains as specialty chemicals earnings support valuation
Innospec stock is maintaining recent gains, backed by strong 2024 earnings, resilient margins in fuel specialties, and a growing dividend. The company reported a 3.8% year-on-year revenue increase and a 10% rise in adjusted operating income for Q1 2024, driven by its fuel specialties and performance chemicals segments. Its consistent dividend growth, robust cash generation, and moderate leverage further support the investment case in the specialty chemicals sector.
Innospec stock steadies as specialty chemicals group highlights cash generation
Innospec Inc. (IOSP) has reported stable but mixed financial results for fiscal 2023, showcasing modest revenue growth alongside stronger cash generation and consistent dividends. Despite nearly flat sales year-on-year, the company maintained profitability due to cost discipline and product mix, with operating cash flow improving significantly. Innospec continues to return capital to shareholders through dividends and modest share repurchases, with performance chemicals being a key driver of value.
(IOSP) and the Role of Price-Sensitive Allocations
This article provides an analysis of Innospec Inc. (NASDAQ: IOSP) focusing on its near-term strong sentiment and neutral mid-to-long-term outlook. It highlights a mid-channel oscillation pattern and an exceptional 28.3:1 risk-reward short setup. The analysis includes AI-generated trading strategies for different risk profiles and a multi-timeframe signal analysis, providing key support and resistance levels.
Innospec stock trades steadily as specialty chemicals group balances growth and margins
Innospec Inc. (IOSP) reported increased revenue and earnings in fiscal 2024, with revenue up 6% to $1.8 billion and adjusted EPS rising 11% to $5.20, demonstrating a balance between growth and margin discipline. The company's Performance Chemicals segment was a key growth driver, supported by Fuel Specialties and Oilfield Services. Innospec also maintains a strong balance sheet, solid cash flow, and a growing dividend, emphasizing disciplined capital allocation and sustainability efforts.
